25.86
price up icon2.99%   0.75
after-market 시간 외 거래: 26.40 0.54 +2.09%
loading
전일 마감가:
$25.11
열려 있는:
$25.63
하루 거래량:
1.04M
Relative Volume:
1.88
시가총액:
$1.78B
수익:
$71.30M
순이익/손실:
$-354.80M
주가수익비율:
-4.6261
EPS:
-5.59
순현금흐름:
$-356.00M
1주 성능:
+15.04%
1개월 성능:
-2.67%
6개월 성능:
-28.07%
1년 성능:
+20.78%
1일 변동 폭
Value
$25.13
$26.55
1주일 범위
Value
$21.17
$26.55
52주 변동 폭
Value
$21.17
$53.08

Arvinas Inc Stock (ARVN) Company Profile

Name
명칭
Arvinas Inc
Name
전화
203-535-1456
Name
주소
395 WINCHESTER AVE, NEW HAVEN, CT
Name
직원
445
Name
트위터
@ArvinasInc
Name
다음 수익 날짜
2024-10-30
Name
최신 SEC 제출 서류
Name
ARVN's Discussions on Twitter

ARVN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
ARVN 25.86 1.78B 71.30M -354.80M -356.00M -5.59
VRTX 450.97 116.14B 10.63B -479.80M -1.35B 13.33
REGN 738.00 81.10B 13.85B 4.65B 3.32B 35.06
ARGX 605.92 36.23B 1.86B -40.29M -1.28B -4.16
ALNY 244.89 31.59B 2.09B -332.26M 16.06M -4.14
BNTX 113.13 27.12B 3.30B -501.07M 1.03B 11.54

Arvinas Inc Stock (ARVN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-02-14 다운그레이드 Citigroup Buy → Neutral
2024-02-01 개시 Goldman Buy
2023-12-19 업그레이드 Wells Fargo Equal Weight → Overweight
2023-12-06 업그레이드 Jefferies Hold → Buy
2023-11-20 업그레이드 Guggenheim Neutral → Buy
2023-10-23 업그레이드 Wedbush Neutral → Outperform
2023-06-26 재개 Oppenheimer Outperform
2023-01-12 다운그레이드 Guggenheim Buy → Neutral
2023-01-03 다운그레이드 Wells Fargo Overweight → Equal Weight
2022-09-09 개시 Barclays Overweight
2022-06-21 개시 Jefferies Hold
2022-05-09 다운그레이드 Wedbush Outperform → Neutral
2022-04-28 개시 Credit Suisse Outperform
2022-04-06 개시 Morgan Stanley Equal-Weight
2022-02-11 재개 BMO Capital Markets Outperform
2022-02-10 개시 Wells Fargo Overweight
2022-01-19 개시 Goldman Buy
2021-12-07 개시 Cowen Outperform
2021-10-14 개시 SVB Leerink Outperform
2021-09-30 개시 Stifel Buy
2021-09-09 개시 BofA Securities Buy
2021-05-21 개시 UBS Buy
2021-04-21 개시 Truist Buy
2021-03-31 개시 BMO Capital Markets Outperform
2020-12-14 업그레이드 Oppenheimer Perform → Outperform
2020-06-01 업그레이드 Citigroup Neutral → Buy
2020-05-12 개시 Oppenheimer Perform
2019-12-19 개시 H.C. Wainwright Buy
2019-11-25 개시 Guggenheim Buy
2019-10-24 업그레이드 Goldman Neutral → Buy
2019-09-25 개시 Wedbush Outperform
2019-09-12 개시 BMO Capital Markets Outperform
2019-08-06 개시 Cantor Fitzgerald Overweight
2019-06-05 다운그레이드 Citigroup Buy → Neutral
2019-04-12 개시 Evercore ISI Outperform
2018-10-22 개시 Citigroup Buy
2018-10-22 개시 Goldman Neutral
2018-10-22 개시 Piper Jaffray Overweight
모두보기

Arvinas Inc 주식(ARVN)의 최신 뉴스

pulisher
Nov 22, 2024

Metastatic Prostate Cancer Market to Show Remarkable Growth Trends from 2023 to 2032, DelveInsight Reports | Merck, Arvinas Androgen Receptor, Novartis, UNICANCER, Aragon Pharma, Mark Stein - Barchart

Nov 22, 2024
pulisher
Nov 22, 2024

Pfizer, Arvinas delay late-stage trial for breast cancer therapy - MSN

Nov 22, 2024
pulisher
Nov 22, 2024

Metastatic Prostate Cancer Market to Show Remarkable Growth - openPR

Nov 22, 2024
pulisher
Nov 22, 2024

Leerink Partnrs Issues Negative Outlook for Arvinas Earnings - MarketBeat

Nov 22, 2024
pulisher
Nov 21, 2024

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Arvinas, Inc. (ARVN) And Encourages Investors to Reach Out - AccessWire

Nov 21, 2024
pulisher
Nov 21, 2024

(ARVN) Technical Pivots with Risk Controls - Stock Traders Daily

Nov 21, 2024
pulisher
Nov 20, 2024

Arvinas stock remains a Top Pick despite slight reduction in price target, says BMO - Investing.com

Nov 20, 2024
pulisher
Nov 20, 2024

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Arvinas, Inc. (ARVN) And Encourages Stockholders to Reach Out - AccessWire

Nov 20, 2024
pulisher
Nov 20, 2024

Unveiling 4 Analyst Insights On Arvinas - Benzinga

Nov 20, 2024
pulisher
Nov 20, 2024

Arvinas shares target cut to $62 on delayed trial data By Investing.com - Investing.com Canada

Nov 20, 2024
pulisher
Nov 20, 2024

Arvinas shares target cut to $62 on delayed trial data - Investing.com

Nov 20, 2024
pulisher
Nov 19, 2024

Arvinas reports delay in breast cancer trial results - Investing.com India

Nov 19, 2024
pulisher
Nov 19, 2024

Arvinas reports delay in breast cancer trial results By Investing.com - Investing.com UK

Nov 19, 2024
pulisher
Nov 19, 2024

Arvinas, Inc. (ARVN): This Small-Cap Stock Is Ready To Explode - Insider Monkey

Nov 19, 2024
pulisher
Nov 18, 2024

Stephens Begins Coverage on Arvinas (NASDAQ:ARVN) - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

Short Interest in Arvinas, Inc. (NASDAQ:ARVN) Drops By 5.6% - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

Stephens & Co. Initiates Coverage of Arvinas (ARVN) with Overweight Recommendation - MSN

Nov 18, 2024
pulisher
Nov 14, 2024

RTW INVESTMENTS, LP Adjusts Stake in Arvinas Inc - GuruFocus.com

Nov 14, 2024
pulisher
Nov 13, 2024

Arvinas chief accounting officer David Loomis sells $10,300 in stock By Investing.com - Investing.com Australia

Nov 13, 2024
pulisher
Nov 12, 2024

Arvinas chief accounting officer David Loomis sells $10,300 in stock - Investing.com

Nov 12, 2024
pulisher
Nov 10, 2024

How the (ARVN) price action is used to our Advantage - Stock Traders Daily

Nov 10, 2024
pulisher
Nov 07, 2024

Arvinas, Inc. (NASDAQ:ARVN) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

Nov 07, 2024
pulisher
Nov 07, 2024

Arvinas, Inc. (NASDAQ:ARVN) Receives $56.92 Consensus Target Price from Analysts - MarketBeat

Nov 07, 2024
pulisher
Nov 06, 2024

Arvinas (ARVN) Stock Price, News & Analysis - MarketBeat

Nov 06, 2024
pulisher
Nov 05, 2024

Arvinas's SWOT analysis: biotech stock poised for pivotal trial results - Investing.com India

Nov 05, 2024
pulisher
Nov 05, 2024

Arvinas's SWOT analysis: biotech stock poised for pivotal trial results By Investing.com - Investing.com Canada

Nov 05, 2024
pulisher
Nov 04, 2024

Allspring Global Investments Holdings LLC Has $182,000 Stake in Arvinas, Inc. (NASDAQ:ARVN) - Defense World

Nov 04, 2024
pulisher
Nov 04, 2024

Arvinas to Participate in Upcoming Investor Conferences - GlobeNewswire

Nov 04, 2024
pulisher
Nov 04, 2024

Arvinas (NASDAQ:ARVN) Receives Buy Rating from HC Wainwright - Defense World

Nov 04, 2024
pulisher
Nov 04, 2024

FY2024 EPS Estimates for Arvinas Reduced by Leerink Partnrs - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Wedbush Issues Pessimistic Estimate for Arvinas Earnings - Defense World

Nov 04, 2024
pulisher
Nov 04, 2024

FY2024 EPS Estimates for Arvinas Cut by Leerink Partnrs - Defense World

Nov 04, 2024
pulisher
Nov 04, 2024

Arvinas (NASDAQ:ARVN) Price Target Lowered to $40.00 at Oppenheimer - Defense World

Nov 04, 2024
pulisher
Nov 01, 2024

Arvinas Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 01, 2024
pulisher
Oct 31, 2024

Oppenheimer cuts Arvinas shares price target to $40 ahead of TACTIVE-U trial - Investing.com

Oct 31, 2024
pulisher
Oct 31, 2024

Arvinas' (ARVN) Buy Rating Reiterated at HC Wainwright - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Arvinas, Inc. (NASDAQ:ARVN) Q3 2024 Earnings Call Transcript - Insider Monkey

Oct 31, 2024
pulisher
Oct 31, 2024

Arvinas, Inc. (ARVN) Reports Q3 Loss, Tops Revenue Estimates - MSN

Oct 31, 2024
pulisher
Oct 31, 2024

Arvinas Inc (ARVN) Q3 2024 Earnings Call Highlights: Strong Reve - GuruFocus.com

Oct 31, 2024
pulisher
Oct 31, 2024

Assenagon Asset Management S.A. Invests $3.44 Million in Arvinas, Inc. (NASDAQ:ARVN) - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Arvinas Inc (ARVN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Promising ... - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Arvinas Inc (ARVN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Promising ... By GuruFocus - Investing.com Canada

Oct 31, 2024
pulisher
Oct 31, 2024

Arvinas Reports Progress in Q3 2024 Financials and Trials - TipRanks

Oct 31, 2024
pulisher
Oct 30, 2024

Arvinas Inc (ARVN) Q3 2024 Earnings: Revenue Soars to $102.4M, B - GuruFocus.com

Oct 30, 2024
pulisher
Oct 30, 2024

Arvinas (NASDAQ:ARVN) Trading 4.3% HigherTime to Buy? - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Arvinas earnings beat by $0.16, revenue topped estimates - Investing.com Canada

Oct 30, 2024
pulisher
Oct 30, 2024

Arvinas Reports Third Quarter 2024 Financial Results and Provides Corporate Update - The Manila Times

Oct 30, 2024
pulisher
Oct 30, 2024

Arvinas, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Oct 30, 2024
pulisher
Oct 29, 2024

Arvinas Inc (ARVN) Q3 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus.com

Oct 29, 2024
pulisher
Oct 29, 2024

Arvinas, Inc. (NASDAQ:ARVN) Short Interest Down 12.7% in October - MarketBeat

Oct 29, 2024
pulisher
Oct 25, 2024

We're Hopeful That Arvinas (NASDAQ:ARVN) Will Use Its Cash Wisely - Yahoo Finance

Oct 25, 2024

Arvinas Inc (ARVN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Arvinas Inc 주식 (ARVN) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Houston John G
President and CEO
Feb 23 '24
Sale
47.05
5,196
244,472
1,036,681
Cassidy Sean A
Chief Financial Officer
Feb 23 '24
Sale
47.05
1,702
80,079
181,916
Peck Ronald
Chief Medical Officer
Feb 23 '24
Sale
47.05
1,699
79,938
67,516
Taylor Ian
Chief Scientific Officer
Feb 23 '24
Sale
47.05
1,701
80,032
147,522
Taylor Ian
Chief Scientific Officer
Jan 04 '24
Option Exercise
16.00
8,252
132,032
109,973
$71.72
price up icon 1.89%
$19.00
price up icon 3.15%
$41.11
price up icon 7.48%
$372.89
price up icon 1.51%
$190.51
price down icon 2.08%
$113.13
price up icon 4.53%
자본화:     |  볼륨(24시간):